Uncategorized
What Analysts Are Saying About Delek US Hldgs Stock
Latest Ratings for DK Date Firm Action From To Mar 2022 B of A Securities Upgrades Underperform Neutral Jan 2022 Morgan Stanley Maintains Underweight Dec 2021 Cowen & Co. Maintains Market Perform View More Analyst Ratings for DK View the Latest Analyst Ratings read more
e.l.f. Beauty Stock: A Deep Dive Into Analyst Perspectives (14 Ratings)
Latest Ratings for ELF Date Firm Action From To Feb 2022 DA Davidson Maintains Buy Jan 2022 Raymond James Maintains Outperform Nov 2021 DA Davidson Maintains Buy View More Analyst Ratings for ELF View the Latest Analyst Ratings read more
Where Inspire Medical Systems Stands With Analysts
Latest Ratings for INSP Date Firm Action From To Feb 2022 SVB Leerink Maintains Outperform Nov 2021 Piper Sandler Maintains Overweight Nov 2021 Wells Fargo Maintains Overweight View More Analyst Ratings for INSP View the Latest Analyst Ratings read more
Demystifying DoubleVerify Holdings: Insights From 12 Analyst Reviews
Latest Ratings for DV Date Firm Action From To Mar 2022 Canaccord Genuity Maintains Buy Mar 2022 RBC Capital Maintains Outperform Mar 2022 Barclays Maintains Equal-Weight View More Analyst Ratings for DV View the Latest Analyst Ratings read more
Analyst Favors Cigna, Alignment Healthcare, Cautious On Peers
Cigna’s Evernorth invests $3.5 billion in Shields Health Solutions as Sycamore acquires the firm, while BofA highlights Cigna’s strong growth outlook. Latest Ratings for CI Date Firm Action From To Mar 2022 Mizuho Maintains Buy Feb 2022 SVB Leerink Maintains Market Perform Feb 2022 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for CI View…
Tesla’s New Master Plan Is Either Genius – Or Just Elon Being Elon
Tesla is making an aggressive pivot toward AI and automation as Musk touts the Dojo supercomputer as central to the company’s future. read more
